Cargando…

Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection

Both lung adenocarcinoma and coronavirus disease 2019 would cause pulmonary inflammation. Angiotensin-converting enzyme 2, the functional receptor of SARS-CoV-2, also plays a key role in lung adenocarcinoma. To study the risk of SARS-CoV-2 infection in lung adenocarcinoma patients, mRNA and microRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Long, Liu, Yue, Wu, Jiamin, Deng, Chao, Tan, Jianjun, Liu, Huawen, Zhong, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880402/ https://www.ncbi.nlm.nih.gov/pubmed/33429366 http://dx.doi.org/10.18632/aging.202375

Ejemplares similares

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
por: Li, Qianqian, et al.
Publicado: (2021)

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus
por: Liu, Ying, et al.
Publicado: (2021)

Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Lung Regeneration
por: Zhao, Fuxiaonan, et al.
Publicado: (2022)

Is Higher Viral Load in SARS-CoV-2 Associated with Death?
por: Faíco-Filho, Klinger Soares, et al.
Publicado: (2020)

Patients with Chronic Kidney Disease Have Higher Acute Kidney Injury Morbidity than those without after SARS-CoV-2 Infection
por: Song, Yuting, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Imaging Progression Under Low Respiratory Viral Load of SARS-CoV-2 Omicron Variant Infection: A Retrospective Study in China
por: Li, Qi, et al.
Publicado: (2023)

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
por: Yue, Can, et al.
Publicado: (2023)

BCG and SARS-CoV-2—What Have We Learned?
por: Kulesza, Jakub, et al.
Publicado: (2022)

The SARS-CoV-2 Omicron Variant Does Not Have Higher Nasal Viral Loads Compared to the Delta Variant in Symptomatic and Asymptomatic Individuals
por: Laitman, Andrew M., et al.
Publicado: (2022)

The risk of pancreatic adenocarcinoma following SARS-CoV family infection
por: Ebrahimi Sadrabadi, Amin, et al.
Publicado: (2021)

Lung Epithelial Cells from Obese Patients Have Impaired Control of SARS-CoV-2 Infection
por: Gaudet, Mellissa, et al.
Publicado: (2023)

Transcriptomic analysis reveals novel mechanisms of SARS‐CoV‐2 infection in human lung cells
por: Yang, Shaomin, et al.
Publicado: (2020)

A protective AAV vaccine for SARS-CoV-2
por: Zhao, Simeng, et al.
Publicado: (2022)

Biomimetic Nanotechnology for SARS-CoV-2 Treatment
por: Li, Shuo, et al.
Publicado: (2023)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability
por: Hirose, Ryohei, et al.
Publicado: (2022)

Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models
por: Liu, Hsin-Liang, et al.
Publicado: (2020)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Perinatal outcomes of pregnant women having SARS-CoV-2 infection
por: Arinkan, Sevcan Arzu, et al.
Publicado: (2021)

Does the SARS-CoV-2 spike really have an Achilles heel?
por: Pillai, Shiv
Publicado: (2023)

Smoking and SARS-CoV-2: Are Polish health professionals at higher risk of infection?
por: Koczkodaj, Paweł, et al.
Publicado: (2020)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
por: Anderson, Elizabeth M., et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis()
por: Bonilla-Aldana, D. Katterine, et al.
Publicado: (2020)

Laboratory management for large‐scale population screening for SARS‐CoV‐2
por: Duan, Xiuzhi, et al.
Publicado: (2021)

Lung Organoids as Model to Study SARS-CoV-2 Infection
por: Peng, Li, et al.
Publicado: (2022)

Genomics functional analysis and drug screening of SARS-CoV-2
por: Chen, Long, et al.
Publicado: (2020)

Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant
por: Li, Maojun, et al.
Publicado: (2022)

Lung ultrasound in early SARS-CoV-2 pneumonia and the LUS-CoV criteria
por: Jalil, Bilal A., et al.
Publicado: (2020)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

SARS-CoV-2 and the Nucleus
por: Chen, Mengqi, et al.
Publicado: (2022)

Evaluation of the presence of SARS-CoV-2 in vaginal and anal swabs of women with omicron variants of SARS-CoV-2 infection
por: Liu, Ding, et al.
Publicado: (2022)

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
por: Scialo, Filippo, et al.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iuc9o1hoqji3d1jnia2gsgcih8